Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX3WDD
|
||||
| Drug Name |
1-(biphenyl-4-yl)-3-(4-(2-methoxyphenyl)piperazin-1-yl)propan-1-ol
|
||||
| Synonyms |
CHEMBL135824
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H30N2O2
|
||||
| Canonical SMILES |
COc1ccccc1N2CCN(CCC(O)c3ccc(cc3)c4ccccc4)CC2
|
||||
| InChI |
InChI=1S/C26H30N2O2/c1-30-26-10-6-5-9-24(26)28-19-17-27(18-20-28)16-15-25(29)23-13-11-22(12-14-23)21-7-3-2-4-8-21/h2-14,25,29H,15-20H2,1H3
|
||||
| InChIKey |
LLNFVVXSTGRSIR-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.